Neurology and Therapy: 2023, vol: , issue:
- 1)- Russell Rosenberg, Rogelio Braceras, Wayne Macfadden, Shawn Candler, Jed Black, Chad Ruoff. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary. Neurology and therapy. 2023, 12 (6): 1805-1820
Cited : 5Read More - 2)- Rita Sattler, Bryan J Traynor, Janice Robertson, Ludo Van Den Bosch, Sami J Barmada, Clive N Svendsen, Matthew D Disney, Tania F Gendron, Philip C Wong, Martin R Turner, Adam Boxer, Suma Babu, Michael Benatar, Michael Kurnellas, Jonathan D Rohrer, Christopher J Donnelly, Lynette M Bustos, Kendall Van Keuren-Jensen, Penny A Dacks, Marwan N Sabbagh, . Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit. Neurology and therapy. 2023, 12 (6): 1821-1843Cited : 9Read More
- 3)- Taoufik Alsaadi, Deeb M Kayed, Abubaker Al-Madani, Ali Mohamed Hassan, Alessandro Terruzzi, Derk Krieger, Naji Riachi, Pournamy Sarathchandran, Suhail Al-Rukn. Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE. Neurology and therapy. 2023, 12 (6): 1845-1865Cited : 3Read More
- 4)- Angelo Ghezzi, R F Neuteboom. Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment. Neurology and therapy. 2023, 12 (6): 1867-1881Cited : 4Read More
- 5)- Arthur Esquer, Frédéric Blanc, Nicolas Collongues. Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer's Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion. Neurology and therapy. 2023, 12 (6): 1883-1907Cited : 4Read More
- 6)- Scott D Newsome, Cherie Binns, Ulrike W Kaunzner, Seth Morgan, June Halper. No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]. Neurology and therapy. 2023, 12 (6): 1909-1935Cited : 5Read More
- 7)- Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri, Susan R Criswell, Erik H Danielsen, Florin Gandor, Jia Jia, Thomas E Kimber, Hideki Mochizuki, Weining Z Robieson, Amy M Spiegel, David G Standaert, Saritha Talapala, Maurizio F Facheris, Victor S C Fung. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurology and therapy. 2023, 12 (6): 1937-1958Cited : 20Read More
- 8)- Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri, Susan R Criswell, Erik H Danielsen, Florin Gandor, Jia Jia, Thomas E Kimber, Hideki Mochizuki, Weining Z Robieson, Amy M Spiegel, David G Standaert, Saritha Talapala, Maurizio F Facheris, Victor S C Fung. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurology and therapy. 2023, 12 (6): 1959-1960Cited : 0Read More
- 9)- Crystal Watson, Dhanalakshmi Thirumalai, Arie Barlev, Eddie Jones, Sasha Bogdanovich, Kiren Kresa-Reahl. Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021. Neurology and therapy. 2023, 12 (6): 1961-1979Cited : 3Read More
- 10)- Noboru Imai, Yuki Isogai, Yoshiyuki Shibasaki, Masami Nakai, Miki Ishida, Xiaoping Ning, Nobuyuki Koga. Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Neurology and therapy. 2023, 12 (6): 1981-1991Cited : 2Read More
- 11)- Shigekazu Kitamura, Takao Takeshima, Daishi Yui, Gabriel Paiva da Silva Lima, Reija Koukakis, Cheng Peng, Ryuji Yoshida, Yotaro Numachi, Miki Hasebe. Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis. Neurology and therapy. 2023, 12 (6): 1993-2006Cited : 0Read More
- 12)- Mamoru Shibata, Atsuko Nihira, Yuka Tanji, Akichika Ozeki, Hideyuki Imagawa, Mika Komori. Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial. Neurology and therapy. 2023, 12 (6): 2007-2019Cited : 1Read More
- 13)- Yongang Li, GuiKai Ji, Mengjia Lian, Xuan Liu, Ying Xu, Yaxing Gui. Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study. Neurology and therapy. 2023, 12 (6): 2021-2040Cited : 1Read More
- 14)- Radu Tanasescu, Nanci Frakich, I-Jun Chou, Perla Filippini, Giulio Podda, Gao Xin, Ranjithmenon Muraleedharan, Oltita Jerca, David Onion, Cris S Constantinescu. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023, 12 (6): 2041-2052Cited : 2Read More
- 15)- Agnete Skovlund Dissing, Xin Ying Lee, Ole Østerberg, Lene Hammer-Helmich. Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS). Neurology and therapy. 2023, 12 (6): 2053-2065Cited : 3Read More
- 16)- Byron J Aguilar, Donald Miller, Guneet Jasuja, Xuyang Li, Ekaterina Shishova, Maureen K O'Connor, Andrew Nguyen, Peter Morin, Dan Berlowitz, Raymond Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, Weiming Xia. Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer's Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System. Neurology and therapy. 2023, 12 (6): 2067-2078Cited : 5Read More
- 17)- Christopher A Hartford, Steven A Sherman, Stella Karantzoulis, Isabelle Guillemin, Michael G Phinney, Kimberly L Kelly, Kayla E Negron, Shruti M Raja, Diana Rofail. Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity. Neurology and therapy. 2023, 12 (6): 2079-2099Cited : 1Read More
- 18)- Hanbin Wang, Luxuan Wang, Yanli Tan, Chuan Fang, Chunhui Li, Lijian Zhang. Identification of miRNAs Involved in Intracranial Aneurysm Rupture in Cigarette-Smoking Patients. Neurology and therapy. 2023, 12 (6): 2101-2119Cited : 0Read More
- 19)- Jiajia Yao, Rumeng Zhou, Yue Liu, Yin Liu, Qian Cao, Zuneng Lu. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome. Neurology and therapy. 2023, 12 (6): 2121-2132Cited : 2Read More
- 20)- Anne M Ryschon, Khoa N Cao, Asim Roy, Jan B Pietzsch. Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis. Neurology and therapy. 2023, 12 (6): 2133-2146Cited : 1Read More
- 21)- Yuanyuan Gao, Dan Su, Zhouya Xue, Lin Ji, Shu Wang. Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study. Neurology and therapy. 2023, 12 (6): 2147-2160Cited : 4Read More
- 22)- Lisa Belter, Ilse Peterson, Jill Jarecki. Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population. Neurology and therapy. 2023, 12 (6): 2161-2175Cited : 2Read More
- 23)- José E Meca-Lallana, José M Prieto González, Ana B Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas-Rodríguez, Luis A Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gub. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and therapy. 2023, 12 (6): 2177-2193Cited : 0Read More
- 24)- Pelayo Nieto-Gómez, Celia Castaño-Amores. Letter to the Editor Regarding: "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis". Neurology and therapy. 2023, 12 (6): 2195-2197Cited : 0Read More
- 25)- Brittney Lager, Jacob Liseno, Ivan Božin, Sarah M England, Sai L Shankar, Jason P Mendoza, James B Lewin. Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis". Neurology and therapy. 2023, 12 (6): 2199-2203Cited : 0Read More
- 26)- Sarah A Morrow, Paola Kruger, Dawn Langdon, Nektaria Alexandri. What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation. Neurology and therapy. 2023, 12 (5): 1419-1429Cited : 4Read More
- 27)- Federico Carlini, Valeria Lusi, Caterina Rizzi, Francesco Assogna, Alice Laroni. Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review. Neurology and therapy. 2023, 12 (5): 1477-1490Cited : 2Read More
- 28)- Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, Heinz Wiendl, David Paling, Mitzi Williams, Ralf Gold, Andrew Chan, Ron Milo, Ayan Das Gupta, Goeril Karlsson, Roseanne Sullivan, Gordon Graham, Martin Merschhemke, Dieter A Häring, Patrick Vermersch. The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment. Neurology and therapy. 2023, 12 (5): 1491-1515Cited : 13Read More
- 29)- Pareena Chaitanuwong, Panisa Singhanetr, Methaphon Chainakul, Niracha Arjkongharn, Paisan Ruamviboonsuk, Andrzej Grzybowski. Potential Ocular Biomarkers for Early Detection of Alzheimer's Disease and Their Roles in Artificial Intelligence Studies. Neurology and therapy. 2023, 12 (5): 1517-1532Cited : 3Read More
- 30)- Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, Stewart J Tepper, Larry Charleston, Stephen Landy, Deena E Kuruvilla, Aubrey Manack Adams. Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review. Neurology and therapy. 2023, 12 (5): 1533-1551Cited : 3Read More
- 31)- Ziyi Shen, Nana Bao, Ming Tang, Yang Yang, Jia Li, Wei Liu, Guohui Jiang. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Neurology and therapy. 2023, 12 (5): 1553-1572Cited : 8Read More
- 32)- Yazan Bader, Reem Suliman, Mohamad Harb, Vanessa Santos, Ibrahim Al Qaisi, Taoufik Alsaadi. Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study. Neurology and therapy. 2023, 12 (5): 1683-1693Cited : 5Read More
- 33)- Mei He, Wenjing Wang, Qiang He, Heling Dai, Jinming Han, Wenyao Cui. Genetic Causal Association Between the Gut Microbiome and Intracranial Aneurysm and Subarachnoid Hemorrhage: A Two-Sample Mendelian Randomization Study. Neurology and therapy. 2023, 12 (5): 1695-1707Cited : 4Read More
- 34)- Caroline K Geiger, Danny Sheinson, Tu My To, David Jones, Nicole G Bonine. Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab. Neurology and therapy. 2023, 12 (5): 1709-1728Cited : 3Read More
- 35)- Jinfa Ren, Xiaoyang Zhai, Huijia Yin, Fengmei Zhou, Ying Hu, Kaiyu Wang, Ruifang Yan, Dongming Han. Multimodality MRI Radiomics Based on Machine Learning for Identifying True Tumor Recurrence and Treatment-Related Effects in Patients with Postoperative Glioma. Neurology and therapy. 2023, 12 (5): 1729-1743Cited : 3Read More
- 36)- Xing Wang, Yulu Shi, Yiyi Chen, Ying Gao, Tingting Wang, Zhengyang Li, Yilong Wang. Blood-Brain Barrier Breakdown is a Sensitive Biomarker of Cognitive and Language Impairment in Patients with White Matter Hyperintensities. Neurology and therapy. 2023, 12 (5): 1745-1758Cited : 3Read More
- 37)- Laura Obici, Senda Ajroud-Driss, Kon-Ping Lin, John L Berk, Julian D Gillmore, Parag Kale, Haruki Koike, David Danese, Emre Aldinc, Chongshu Chen, John Vest, David Adams, . Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy. Neurology and therapy. 2023, 12 (5): 1759-1775Cited : 7Read More
- 38)- Shilin Li, Yu Zhang, Xiaobo Zhang, Gejuan Zhang, Nannan Han, Haojun Ma, Hanming Ge, Yong Zhao, Leshi Zhang, Yanfei Wang, Wenzhen Shi, Xiaojuan Ma, Yizhuo Tian, Yixuan Xiao, Yinuo Niu, Lin Qiao, Mingze Chang. The Functional Prognosis of Rescue Conscious Sedation During Mechanical Thrombectomy on Patients with Acute Anterior Circulation Ischemic Stroke: A Single-Center Retrospective Study. Neurology and therapy. 2023, 12 (5): 1777-1789Cited : 2Read More
- 39)- Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana. Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy. 2023, : Cited : 0Read More
- 40)- Shigeyuki Tahara, Fumio Otsuka, Takaaki Endo. Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey. Neurology and therapy. 2023, : Cited : 1Read More
- 41)- Luis Genis-Najera, Maria Elena Sañudo-Maury. Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions. Neurology and therapy. 2023, : Cited : 0Read More
- 42)- Xiaoling Pan, Yingjian Pei, Meixia Zhang, Wansi Zhong, Jin Hu, Zhimin Wang, Dongjuan Xu, Min Lou, Hongfang Chen, Zhicai Chen. Association of Atrial Fibrillation with Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results from a Multicenter Study in China. Neurology and therapy. 2023, : Cited : 2Read More
- 43)- Huijuan Wan, Qi Liu, Chao Chen, Wenyu Dong, Shengsong Wang, Weixiong Shi, Chengyu Li, Jiechuan Ren, Zhanxiang Wang, Tao Cui, Xiaoqiu Shao. An Integrative Nomogram for Identifying Cognitive Impairment Using Seizure Type and Cerebral Small Vessel Disease Neuroimaging Markers in Patients with Late-Onset Epilepsy of Unknown Origin. Neurology and therapy. 2023, : Cited : 1Read More
- 44)- Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, Jerome De Sèze, Patrick Vermersch, Ali-Frederic Ben-Amor, Carine Savarin, Gilles Defer. Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis. Neurology and therapy. 2023, : Cited : 0Read More
- 45)- Sandra Parawira, Victoria Reese. Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States. Neurology and therapy. 2023, : Cited : 0Read More
- 46)- Todd J Schwedt, Tina M Myers Oakes, James M Martinez, Bert B Vargas, Hitendra Pandey, Eric M Pearlman, Diane R Richardson, Oralee J Varnado, Michael Cobas Meyer, Peter J Goadsby. Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial. Neurology and therapy. 2023, : Cited : 12Read More
- 47)- Sui-Yi Xu, Qi Zhang, Chang-Xin Li. Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management Challenges. Neurology and therapy. 2023, : Cited : 1Read More
- 48)- Jessica Braid. Letter to the Editor Regarding "Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study". Neurology and therapy. 2023, : Cited : 0Read More
- 49)- Richard B Lipton, Janette Contreras-De Lama, Daniel Serrano, Ella Engstrom, Nicolai D Ayasse, Weijie Poh, François Cadiou, Aubrey Manack Adams. Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE. Neurology and therapy. 2023, : Cited : 2Read More
- 50)- Leigh F Callahan, Brian Samsell, Dana DiBenedetti, Terry Frangiosa, Christina Slota, Virginia Biggar, Russ Paulsen, Debra Lappin, William L Herring, Carla Romano. Evaluating Elements of the Care Partner Experience in Individuals Who Care for People with Alzheimer's Disease Across the Severity Spectrum. Neurology and therapy. 2023, : Cited : 0Read More
